Jay M. Lee, MD

Jay Moon Lee, MD

Associate Professor and Chief, Department of Surgery, Thoracic Surgery
Surgical Director, UCLA Thoracic Oncology Program
Surgical Director, UCLA Center for Esophageal Disorders




Thoracic Surgery/Cardiothoracic Surgery

Institutional Affiliation

Ronald Reagan UCLA Medical Center



CardioThoracic Surgery, Brigham and Women's Hospital, 2004 - 2006


Surgery, Georgetown University Medical Center, 1997 - 1998


MD, UCLA School of Medicine, 1997


Surgery, Duke University Medical Center, 2001 - 2004
Surgery, Georgetown University Medical Center, 1998 - 1999

Board Certifications

Surgery, American Board of Surgery, 2004
Surgery, American Board of Thoracic Surgery, 2009

Contact Information


(310) 794-7788 - Surgery patient appointments
(310) 794-7333 - Thoracic Surgery patient appointments
(310) 825-9111 - Thoracic Surgery medical center operator
(310) 825-6301 - Thoracic Surgery medical center page operator
(310) 794-7333 - Lung Cancer Program and General Thoracic Surgery information and patient appointments
(310) 206-6909 - Thoracic Oncology Program information and referral
(310) 825-7086 - Sarcoma Program information and referral

Clinical Interests

Esophageal, Lung, Lung Cancer and Chest Malignancies, Mesothelioma, Sarcoma, Thoracic, Thoracic Cancer, Thymus, Trachea

Scientific Interests

Dr. Jay Lee is interested in immunotherapy and gene therapy in lung cancer and the application of nanotechnology as a treatment and imaging modality in lung cancer.

Highlighted Publications

Kachroo P, Pak PS, Sandha HS, Lee C, Elashoff D, Nelson SD, Chmielowski B, Selch MT, Cameron RB, Holmes EC, Eilber FC, Lee JM. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas. J Thorac Oncol. 2012 Mar;7(3):552-8.

Kachroo P, Pak PS, Sandha HS, Nelson SD, Seeger LL, Cameron RB, Eilber FC, Lee JM. Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy. J Thorac Oncol. 2012 Jan;7(1):151-6.

Lee G, Gardner BK, Elashoff DA, Purcell CM, Sandha HS, Mao JT, Krysan K, Lee JM, Dubinett SM. Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients. Am J Transl Res. 2011 May 15;3(3):226-33.

Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res. 2010 Jun 30;2(4):356-67.

Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med. 2008 Jul 22;6:38.